Combination therapy using active immunotherapy
作者： Toni Weinschenk , Steffen Walter , Norbert Hilf , Niels Emmerich , Harpreet Singh
DOI:
关键词:
摘要: The present invention relates to methods of treating cancer in a mammal comprising administering the combination therapy vaccine and multi-kinase inhibitor, wherein comprises an isolated tumor associated peptide having ability bind molecule human major histocompatibility complex (MHC) class-I or class-II. Preferably inhibitor is sunitinib malate and/or sorafenib tosylate pharmaceutically acceptable salt thereof.
google.com.ar参考文章(68)
Wei-Chiang Shen, Jiansheng Wan, Compositions and methods for enhanced transepithelial and transendothelial transport or active agents ,(1991)
Tatiana Seregina, Charles J. Link, Gabriela Rossi, Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase ,(2003)
Philippe Goyette, Eric Simard, Pierre Lemieux, Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof ,(2003)
Toni Weinschenk, Harpreet Singh, Oliver Schoor, Claudia Trautwein, Peter Lewandrowski, Norbert Hilf, Steffen Walter, Composition of tumour-associated peptides and related anti-cancer vaccine ,(2008)
David Berd, Treatment of tumor cells for use in immunotherapy of cancer ,(2003)
Vincent H. Lee, Wan-Ching Yen, Methods and compositions to enhance epithelial drug transport ,(1994)
Claudio Thomasin, Giampietro Corradin, Ying Men, Bruno Gander, Hans Peter Merkle, Immunological response potentiation process ,(1994)
Toni Weinschenk, Harpreet Singh, Niels Emmerich, Steffen Walter, Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine ,(2006)
Gideon Bollag, John F. Lyons, RAF-MEK-ERK pathway inhibitors to treat cancer ,(2002)